uploads///Chart  EPS Growth Rate

A Review of Pharma Stocks’ EPS Growth Rates

By

Sep. 18 2018, Updated 10:31 a.m. ET

EPS growth rates

In this article, we’ll compare the EPS growth rates of pharmaceutical companies Eli Lilly and Company (LLY), Pfizer (PFE), Merck & Co. (MRK), Allergan (AGN), and GlaxoSmithKline (GSK).

The chart above compares the EPS growth rates of these companies since the first quarter of 2017.

Article continues below advertisement

Eli Lilly

Eli Lilly reported a ~35.1% rise in its EPS in the second quarter. Its adjusted EPS rose to $1.50 in the quarter compared to its EPS of $1.11 in the second quarter of 2017.

Pfizer

Pfizer reported a ~20.9% rise in its EPS in the second quarter. Its adjusted EPS rose to $0.81 in the quarter compared to its EPS of $0.67 in the second quarter of 2017.

Article continues below advertisement

Merck & Co.

Merck & Co. reported a ~4.9% rise in its EPS in the second quarter. Its adjusted EPS rose to $1.06 in the quarter compared to its EPS of $1.01 in the second quarter of 2017.

Allergan

Allergan reported a ~9.9% rise in its EPS in the second quarter. Its adjusted EPS rose to $4.42 in the quarter compared to its EPS of $4.02 in the second quarter of 2017.

GlaxoSmithKline

GlaxoSmithKline reported a ~3.3% rise in its EPS in the second quarter. Its adjusted EPS rose to 28.10 British pence in the quarter compared to its EPS of 27.20 pence in the second quarter of 2017.

We’ll discuss the quarterly revenue performances of and 2018 estimates for each of these companies in the coming articles.

The iShares US Healthcare ETF (IHE) holds 6.9% in Eli Lilly, 9.3% in Pfizer, 8.2% in Merck & Co., and 5.7% in Allergan.

Advertisement

More From Market Realist

    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.